Magnesium Sulfate as an Adjunctive Analgesic in Prostate Surgery

Launched by NYU LANGONE HEALTH · Jun 26, 2024

Keywords

ClinConnect Summary

This clinical trial is studying the use of magnesium sulfate as a pain-relief option for men undergoing prostate surgery, specifically robotic prostatectomy. The researchers want to find out if adding magnesium sulfate to the standard anesthesia can help reduce pain during and after the surgery. Participants in the study will be randomly selected to either receive magnesium sulfate or not, allowing the team to compare the results between the two groups. They will look for improvements in pain levels, as well as whether magnesium helps reduce the need for other pain medications, limits postoperative shivering, and aids in a quicker recovery for going home.

To be eligible for this trial, participants need to be at least 18 years old and scheduled for robotic prostate surgery under general anesthesia. They must also be able to give their consent to join the study. However, those with severe kidney disease, known allergies to magnesium sulfate, or who may have trouble following the study procedures will not be able to participate. If you or a loved one qualifies and decides to take part, you can expect to receive either the magnesium sulfate or standard treatment during surgery and to be monitored closely for any effects on pain and recovery.

Gender

MALE

Eligibility criteria

• Inclusion Criteria:
• • 1. Age 18 and older.
• • 2. Undergoing a robotic prostatectomy under general anesthesia.
• • 3. Is willing and able to provide consent to participate in the study.
• Exclusion Criteria:
• • 1. Patients younger than 18 years
• • 2. Patients with end-stage renal disease
• • 3. Known allergy to magnesium sulfate preparations
• • 4. Any patient that the investigators feel cannot comply with all study related procedures